Covid-19: UK will offer third vaccine dose to severely immunosuppressed people

نویسندگان

چکیده

The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has recommended that people with severely weakened immune systems should have a third vaccine dose as part of their primary vaccination schedule against covid-19. The either the Moderna or Pfizer-BioNTech be offered to over age 12 who were immunosuppressed at time first second dose, including those leukaemia, advanced HIV, recent organ transplants. For 12-17 year olds is preferred. The JCVI still deciding benefits booster doses for rest population awaiting further evidence inform this decision. The committee based its new advice …

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Strategies of vaccine production against COVID-19: when will an effective vaccine be produced?

There is a strong consensus globally that production of an effective vaccine against SARS-CoV-2 is likely the most effective approach to sustainably controlling the COVID-19 pandemic. An unprecedented research effort and global coordination has resulted in a rapid development of vaccine candidates and initiation of trials. In this paper, we review vaccine candidate against COVID-19 and also cha...

متن کامل

Ethical Issues in COVID-19 Vaccine Rollout

From the beginning of the COVID-19 pandemic, researchers aspired to produce an effective vaccine with appropriate efficacy and low side effects to mitigate the pandemic. It seems that vaccination is the only mean to save the world from this pandemic. In this article, we will review the ethical challenges of mass vaccination (focusing on the vaccine distribution and uptake), referring to the mai...

متن کامل

Hydroxychloroquine: A bridge prophylaxis till finding the COVID-19 vaccine

Regarding the importance of COVID-19 pandemic and risks that the infection imposes on healthcare workers, this manuscript discusses the potential usage of Hydroxychloroquine as a prophylactic agent.

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: BMJ

سال: 2021

ISSN: ['0959-8138']

DOI: https://doi.org/10.1136/bmj.n2160